Harmony Biosciences Holdings (HRMY) Interest Coverage Ratio (2023 - 2026)
Harmony Biosciences Holdings recorded quarterly Interest Coverage Ratio of 2.58 in Q1 2026, up 107.33% quarter-over-quarter from 35.18 in Q4 2025, and down 82.42% year-over-year from 14.66 in Q1 2025.
Harmony Biosciences Holdings' Interest Coverage Ratio history runs 4 years deep, the most recent figure standing at 2.58 for Q1 2026.
- In Q1 2026, Interest Coverage Ratio fell 82.42% year-over-year to 2.58; the TTM figure through Mar 2026 stood at 0.2 (down 101.68% YoY), while the FY2025 annual figure was 3.08, down 71.73% from the prior year.
- Interest Coverage Ratio came in at 2.58 for Q1 2026 at Harmony Biosciences Holdings, up from 35.18 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 18.09 in Q3 2025 to a low of 35.18 in Q4 2025.
- A 4-year average of 6.87 and a median of 9.2 in 2023 frame the typical range for Interest Coverage Ratio.
- On a YoY basis, Interest Coverage Ratio climbed as much as 172.51% in 2025 and fell as far as 365.71% in 2025.
- Harmony Biosciences Holdings' Interest Coverage Ratio stood at 8.38 in 2023, then surged by 57.97% to 13.24 in 2024, then tumbled by 365.71% to 35.18 in 2025, then surged by 107.33% to 2.58 in 2026.
- According to Business Quant data, Interest Coverage Ratio over the past three periods registered 2.58, 35.18, and 18.09 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -129.79 |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 3.58 |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -258.33 |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 11.50 |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 49.84 |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 3.88 |
| 10 | Harmony Biosciences Holdings | 1.83 Bn | 1.19 Bn | 170.88 Mn | 2.58 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.58 |
| Dec 31, 2025 | -35.18 |
| Sep 30, 2025 | 18.09 |
| Jun 30, 2025 | 13.21 |
| Mar 31, 2025 | 14.66 |
| Dec 31, 2024 | 13.24 |
| Sep 30, 2024 | 14.19 |
| Jun 30, 2024 | 4.85 |
| Mar 31, 2024 | 11.47 |
| Dec 31, 2023 | 8.38 |
| Sep 30, 2023 | 9.20 |
| Jun 30, 2023 | 7.54 |
| Mar 31, 2023 | 7.05 |